Tabula Rasa HealthCare acquired DoseMe for $30m.

Tabula Rasa HealthCare, a healthcare technology company advancing the field of medication safety, acquired DoseMe, the developer of DoseMeRx™, an advanced precision dosing tool that helps physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes, for $30m. “What a terrific way to start 2019,” said TRHC’s Chairman and CEO Calvin H. Knowlton, Ph.D. “Not only is TRHC combining DoseMe’s state-of-the-art decision support tool with our ability to predict and prevent harmful drug interactions through tools such as the MRM Matrix®, which we are now able to offer hospitals, we have added two exceptional executives to our ranks. Together, we believe we can power the shift to precision prescribing, tailoring medication to meet individual needs and tolerances, which we believe will have a profound impact on safety, quality, and costs, such as medication-related increased hospital length-of-stay.”